The transcription factor Nurr1 (NR4A2) has been found to play a critical role in the development of midbrain dopaminergic neurons. Nurr1 heterozygous ( þ /À) male and female mice expressing 35-40% of normal levels of Nurr1 were generated and examined in animal models related to symptoms of schizophrenia. The Nurr1 ( þ /À) mice displayed hyperactivity in a novel environment, which persisted after administration of the dopamine-mimetic amphetamine and the N-methyl-D-aspartate receptor antagonist phencyclidine. The Nurr1 ( þ /À) mice were deficient in the retention of emotional memory and showed an enhanced response to swim stress. In addition, Nurr1 ( þ /À) male mice displayed a reduced dopamine turnover in the striatum and an enhanced dopamine turnover in the prefrontal cortex, while female mice showed an opposite pattern. These results show that Nurr1 ( þ /À) mice display a pattern of behaviors indicative of potential relevance for symptoms of schizophrenia combined with a gender-specific abnormal dopamine transmission in the striatum and prefrontal cortex, respectively. This suggests that the Nurr1 mutant mouse may be a potential animal model for studies on some of the behavioral and molecular mechanisms underlying schizophrenia.
Introduction
Schizophrenia is a neuropsychiatric disorder characterized by positive symptoms (delusions, hallucinations and paranoia) and/or persistent negative symptoms (flattened affect, impaired attention, social withdrawal and cognitive impairments). 1 The pathophysiology of schizophrenia has, in the last four decades, been associated with dysfunctions in dopamine (DA) neurotransmission. 2 This hypothesis is partly based on the observation that the clinical efficacy of antipsychotic drugs correlates with their blocking affinities for the DA D 2 receptor. 3, 4 In addition, psychostimulant drugs such as amphetamine (AMPH), which increase brain DA transmission, can induce and exacerbate psychotic symptoms in volunteers and schizophrenic patients, respectively. 5 Research on the etiology of schizophrenia has been focussed on possible dysfunctions within the major dopaminergic cell groups located in the ventral region of the midbrain (Mb) including the substantia nigra pars compacta (SNpc) (A9 cell group) and ventral tegmental area (VTA) (A10 cell group). The A9 neurons form the nigrostriatal pathway, which has an important role in motor control, but also in cognitive and emotional behaviors. 6 A10 neurons innervate the limbic system and parts of the medial prefrontal cortex (pFCx) to form the mesocorticolimbic pathway. This DA pathway plays an important role in locomotor activity, emotion, motivation and working memory. 7, 8 In addition to the mesocortical/mesolimbic DA pathway there is accumulating evidence for a role of glutamate and N-methyl-D-aspartate (NMDA) glutamate receptors in schizophrenia. 9 Glutamate and DA, which share common postsynaptic targets, are believed to interact in a reciprocal manner at both cortical and subcortical structures. 10 Thus, a reduction in DA transmission may act to balance a glutamatergic insufficiency in schizophrenia. 10 Some of the symptoms in schizophrenia appear to involve disturbances in NMDA receptor function in the pFCx, probably mediated via alterations in DA receptor activity. 8, 11 Interestingly the noncompetitive NMDA antagonist phencyclidine (PCP) has been shown to induce both positive and negative schizophrenic symptoms as well as cognitive deficits. 12 In rodents PCP administration produces a wider range of schizophrenic symptomatology than AMPH. 13 Some of the behavioral effects of PCP in rodents, for example, the hyperactivity, are blocked or attenuated by current antipsychotic drugs for example DA receptor antagonists 14 indicating that the behavioral effects of NMDA receptor blockade at least partly involve changes in DA transmission.
The pathogenesis of schizophrenia appears to involve subtle disturbances in neurodevelopment resulting into aberrant cortical afferent-efferent functional connectivity. 15 The causes of these disturbances may be genetic and/or environmental. In this context, the transcription factor Nurr1 (NR4A2), a member of the orphan nuclear receptor steroid/ thyroid hormone receptor superfamily, is of special interest. Nurr1 has been identified as a critical genetic factor for the terminal differentiation of midbrain DA neurons in the SNpc and VTA. [16] [17] [18] Nurr1 has also been shown to regulate key genes of critical importance for DA neurotransmission. 16, 19, 20 Nurr1 is expressed predominantly in limbic areas and in the ventral midbrain DA neurons, where its distribution overlaps with DA-containing neurons. 21 Since Nurr1 expression continues into adulthood, its role in controlling DA neurons has important implications not only for the developing brain, but also for the adult brain. Given the role of Nurr1 in shaping the DA phenotype, it is conceivable that Nurr1 mutations could play a role in a chronic disorder such as schizophrenia and/or bipolar disorders. 22, 23 Nurr1 ( þ /À) mice that survive until adulthood are fertile and display no apparent physical defects. Nurr1 ( þ /À) mice have decreased DA levels at 2 months after birth but at 5 months striatal DA is normalized.
16 Nurr1 ( þ /À) male mice were found to have reduced mesolimbic and mesocortical DA levels accompanied with increases in locomotor activity. 24 Since the Nurr1 gene is expressed not only during the development of mesencephalic DA neurons but also is important for differentiating neurons, subtle dysregulations in this transcription factor may result in chronic alterations in DA transmission associated with symptoms of schizophrenia.
To determine the physiological role of Nurr1 gene, we have generated mice heterozygous for the Nurr1 gene. 16 The Nurr1 heterozygous ( þ /À) mice were investigated in a range of behavioral tests relevant for the DA and glutamate hypothesis of schizophrenia.
Materials and methods

Animals
The experiments were conducted according to guidelines approved by the local ethical committee (Stockholm Northern Ethics Board of Animal Experimentation), the European convention for animal care (86-406) and the guide for the care and use of laboratory animals adopted by the National Institutes of Health. Nurr1 heterozygous ( þ /À) mice were generated as previously described. 16 The line was backcrossed for over nine generations with C57Bl/6J mice. The genotype of each animal was determined by polymerase chain reaction of tail DNA using specific probes for the Nurr1 gene. 16 Nurr1 heterozygous ( þ /À) mice were obtained as the F7-F10 generation of Nurr1 heterozygous ( þ /À) intercrosses. Adult male or female Nurr1 heterozygous ( þ /À) mice and their wild-type littermates (25-33 g) aged 5-8 months were used in all experiments. The animals were housed in standard transparent A3 Macrolon (Techniplast, Buguggiate, Italy), (42 Â 26 Â 20 cm) cages, five mice per cage and maintained under a 12 h light-dark cycle (lights on at 0700) at a relative humidity of 50-60% at 21711C. Food and tap water was available ad libitum up to the time of the experiment.
Pharmacological agents D-amphetamine-hydrochloride (D-AMPH; 3 mg/kg), PCP (5 mg/kg) and haloperidol (0.1 mg/kg) were from Sigma (St Louis, MO, USA). The compounds were prepared fresh in saline solution (0.9%) and injected intraperitoneally (i.p.) in a volume of 5 ml/kg.
Behavioral studies
Each behavioral test was performed in independent groups of 8-11 animals per group. All experiments were conducted by one operator in the light phase of circadian cycle between 0900 and 1500 hours. A habituation period of 1 h to the conditions of the experimental room preceded the experimental procedures.
Spontaneous
and drug-induced locomotor activity. Groups consisting of male or female mice received the following treatment: Group I, wildtype
After acclimatization to the experimental room, male or female mice were individually tested in a dimly lit, sound-controlled room. The mice were removed from their home cages and placed in a standard transparent cage (with shavings on the floor) located on the top of the motor activity system.
Locomotor activity was measured simultaneously in eight animals by means of a computerized multicage red and infrared-sensitive motion detection system (Motion Products, Stockholm, Sweden). 25 The system is fully computerized and uses beams of red and infrared lights in combination with vertical and horizontal photocell arrays (4 cm distance between cells) to detect movements of animals. Two different parameters were measured every 10 min for the entire recording period. Locomotion was measured by counting the number of times an animal had covered eight horizontal photocells and moved from one side of the test cage to the other side (a distance of at least 32 cm). Motility was recorded by 48 vertical photocells spaced 4 cm apart, and represents a measure of total activity.
The spontaneous activity of the mice was first recorded for 60 min (the habituation phase). Thereafter, the mice were taken from the test cages and received drug treatment. Following the injection of AMPH (3 mg/kg, i.p.) or PCP (5 mg/kg, i.p.), the activity was recorded for an additional period of 90 min (drug treatment phase). Haloperidol (0.1 mg/kg, i.p.) was administered 30 min before placing the animal in the test cage and locomotor activity was recorded for a 60 min period.
Passive avoidance. Two groups of male or female mice were tested: Group I, wild-type; Group II, Nurr1 heterozygous ( þ /À).
Passive avoidance (PA) was assessed as described earlier for rats 26 using a standard shuttle box adapted for mice (Ugo Basile, Comerio-Varese, Italy), with two communicating compartments of equal size and a stainless steel bar floor. The right-hand compartment (shock compartment) was painted black to create a dark chamber. The left-hand compartment was illuminated by a bulb (24 V; 5 W) installed on the top plexiglass cover. PA training was conducted in a single session (day 1) during the light phase of a 12 h day/night cycle (0900-1500). The mouse was placed in the light compartment with no access to the dark compartment and allowed to explore for 2 min. After this period the sliding door separating the two compartments was automatically opened by pressing a pedal, and the mouse was allowed to enter the dark compartment. Once inside the dark compartment with all four feet, the sliding door was automatically closed and the mouse received a weak electrical current (constant current, scrambled, duration of 2 s, 0.2 mA) delivered through the grid floor. Following exposure to the electrical current the mouse was allowed to stay in the dark compartment for 30 s and was then removed from the PA apparatus. Latency to cross into the dark compartment (training latency) was recorded.
Retention memory was examined 24 h after training. The animal was placed in the light (safe) compartment, with free access to the dark compartment (within 15 s) for a period of 300 s. The latency to enter the dark compartment with all four feet (retention latency) was automatically measured.
Forced-swimming test. Two groups of male mice were examined: Group I, wild-type and Group II, Nurr1 heterozygous ( þ /À). Two swimming sessions were conducted: a 15 min pretest followed by a 6 min test 24 h later. 27 On the first day (preswim) the mice were individually placed for 15 min in a glass cylinder (12 cm in diameter, 23 cm high) filled with tap water (25711C) to the height of 10 cm. The animals were then removed, allowed to dry and returned to their home cage. Twenty-four hours later this procedure was repeated except that the mice were allowed to swim for a 6 min period. The total duration of passive floating (immobility) was measured by a stopwatch. Immobility was defined as floating passively in an upright position with only small movements with one pawn necessary to keep the head above the water surface.
Determination of monoamines and their metabolites
Two weeks after PA test, animals were sacrificed by cervical dislocation. Brains of male and female Nurr1 heterozygous ( þ /À) mice and their wild-type littermates were removed rapidly and cerebellum (Ce), pFCx, Mb, hippocampus (Hp) and striatum (St) were dissected out on ice. The tissue concentrations of DA, homovanillic acid (HVA), 4-dihydroxyphenylacetic acid (DOPAC); serotonin (5-HT); 5-hydroxyindoleacetic acid (5-HIAA), and noradrenaline (NA) were determined in each brain region by high-performance liquid chromatography (HPLC) with electrochemical detection according to a method previously described. 28 The ratio of 5-HIAA/5-HT, DOPAC/DA and HVA/DA were calculated as an index of transmitter turnover. The mobile phase (pH 2.59) used was phosphate/phosphoric acid buffer (0.1 M NaH 2 PO 4 / 30 mM H 3 PO 4 ), sodium octylsulphate (0.29 g/l) and 12.5% methanol. The weighed and frozen samples were homogenized in 0.1 M perchloric acid containing 2.5 mM sodium bisulphite, 1 mM ethylenediaminetetraacetic acid and isoprenaline as internal standard. After centrifugation, the supernatant (50 ml) was injected directly into a Supelcosil LC-18-DB (Supelco, St Louis, MO, USA) (7.5 cm Â 4.6 mm, 3 mm) column, connected to a detector (ESA Coulochem 5100A, ESA Laboratories, Inc., Chelmstors, MA, USA), set to the following potentials: guard cell þ 0.4 V and oxidation
Statistical analysis
Strain-dependent differences in habituation score for locomotion and motility in AMPH and PCP study were analyzed by two-way analysis of variance (ANOVA) for repeated measures, the factors being strain (wild-type and Nurr1 ( þ /À)), treatment (AMPH, PCP) and gender (male and female). This was followed by a post hoc Newman-Keul's test when appropriate for every time point separately. Analysis of total activity for gender during the habituation and treatment period was analyzed by two-way ANOVA followed by two-tailed Student's t-test. Haloperidol study was analyzed by two-way ANOVA for repeated measures the factors being strain (wild-type and Nurr1 ( þ /À)), treatment (saline, haloperidol). PA, FST and monoamine levels were analyzed by Student's t-test.
Results
The locomotor response to novelty is higher in Nurr1 heterozygous ( þ /À) mice Two measures of locomotor activity (locomotion and motility) were monitored for a 1 h period (habituation phase). Nurr1 heterozygous ( þ /À) male mice were significantly more active (82%) than the wild-type male mice both in locomotion (F(1, 22) = 36.33, P < 0.0001) and motility (65%) (F(1, 22) = 32.1, P < 0.0001) (Figure 1a-d) . Total locomotion ( Figure  1a and c) and motility counts confirmed this finding (Figure 1b and d) .
Also Nurr1 heterozygous ( þ /À) female mice were more active (99%) than wild-type control mice in locomotion (F(1, 19) = 8.26, P < 0.010) and motility (68%) (F(1, 19) = 8.7, P < 0.010) (Figure 2c and d) . Unlike the wild-type control mice, Nurr1 ( þ /À) mice did not fully habituate to the test cages during the 1 h test period. Total locomotion (Figure 2a and c) and motility counts confirmed this finding (Figure 2b and d) .
Nurr1-heterozygous ( þ /À) mice display hyperlocomotion after AMPH and PCP administration AMPH stimulated locomotor activity in both male and female mice. After AMPH administration Nurr1 heterozygous ( þ /À) male mice were significantly more active, indicated by measures of locomotion (68%) (F(1, 22) = 6.72, P < 0.01) and motility (64%), than wild-type control mice (F(1, 22) = 9.61, P < 0.01 (Figure 1a and b) . Total locomotion (Figure 1a ) and motility counts confirmed this finding in male mice (Figure 1b) . Maximum significant hyperactivity was observed 40 min after AMPH injection in Nurr1 heterozygous ( þ /À) male mice for both locomotion (P < 0.05) and motility (P < 0.05).
Nurr1 heterozygous ( þ /À) and wild-type control female mice treated with AMPH displayed higher levels of locomotion (90%) (F(1, 19) = 8.2, P < 0.01) and motility (60%) (F(1, 19) = 7.1, P < 0.01) than wildtype control mice (Figure 2a and b) . Maximum hyperactivity was observed at 30 and 20 min following AMPH injection in Nurr1 heterozygous ( þ /À) female mice for both locomotion (P < 0.01) and motility (P < 0.05), respectively.
PCP was found to stimulate locomotor activity in male and female mice at the 5 mg/kg dose. Nurr1 heterozygous ( þ /À) male mice treated with PCP showed a higher activity level than wild-type control mice (Figure 1c and d) , indicated by measures of locomotion (86%) (F(1, 18) = 4.68, P < 0.05) and motility (78%) (F(1, 18) = 4.96, P < 0.05). Total locomotion ( Figure 1c ) and motility was in line with this finding (Figure 1d) . Maximum hyperactivity was observed 20 min after PCP injection in Nurr1 ( þ /À) male mice for both locomotion (P < 0.01) and motility (P < 0.01).
Nurr1 heterozygous ( þ /À) female mice responded more strongly to PCP with regard to locomotion (134%) (F(1, 19) = 6.53, P < 0.01) and motility (87%) (F(1, 19) = 6.6, P < 0.01) than wild-type control mice (Figure 2c and d) in line with total locomotion ( Figure  2c ) and motility counts (Figure 2d) . Maximum hyperactivity was observed 20 min after PCP injection in Nurr1 heterozygous ( þ /À) female mice for both locomotion (P < 0.01) and motility (P < 0.01).
Analysis of gender differences in locomotor response Two-way ANOVA (gender, strain and treatment factors) revealed a highly significant difference in locomotion by gender (F(1, 78) = 23.31, P < 0.0001), strain (F(1, 78) = 38.85, P < 0.0001) and treatment (F(1, 78) = 13.38, P < 0.0001). No interactions were found for strain Â treatment (P = 0.84), strain Â gender (P = 0.151), and treatment Â gender (P = 0.082). Twoway ANOVA (gender, strain and treatment factors) revealed a highly significant difference in motility by gender (F(1, 69) = 6.63, P < 0.01), strain (F(1, 69) = 22.76, P < 0.0001) and treatment (F(1, 69) = 15.03, P < 0.0001) while no interaction was found.
Analysis of total activity for gender during the habituation period showed that wild-type female mice were more active than wild-type male mice in locomotion (137%; P < 0.01, two-tailed Student's t-test) and motility (97%; P < 0.01, two-tailed Student's t-test). Nurr1 heterozygous ( þ /À) female mice were significantly more active than Nurr1 heterozygous ( þ /À) male mice in locomotion (158%; P < 0.01, twotailed Student's t-test) and motility (104%; P < 0.01, two-tailed Student's t-test). AMPH treatment did not result in significant differences between wild-type female and male mice. Also, no difference was found between Nurr1 heterozygous ( þ /À) female and male mice treated with AMPH, although there was a tendency for an enhanced response in wild-type and Nurr1 heterozygous ( þ /À) female mice, compared to the corresponding male mice.
Wild-type control female mice were more stimulated by PCP administration than wild-type males with regard to both locomotion (94%; P < 0.05, twotailed Student's t-test) and motility (108%; P < 0.01, two-tailed Student's t-test). After PCP administration Nurr1 heterozygous ( þ /À) female mice were significantly more active than Nurr1 heterozygous ( þ /À) male mice in locomotion (144%; P < 0.05, twotailed Student's t-test) and motility (119%; P < 0.05, two-tailed Student's t-test).
Haloperidol reduces the locomotor hyperactivity in Nurr1 heterozygous ( þ /À) mice The elevated spontaneous locomotor activity in Nurr1 ( þ /À) mice could be due to enhanced DA activity. To examine this hypothesis, mice were pretreated with haloperidol, a potent DA D 2 receptor antagonist with high receptor specificity. 29 Significant differences between treatment of saline and haloperidol for locomotion (F(1, 18) = 38.1, P < 0.001) and motility (F(1, 18) = 69.6, P < 0.001) were noted. Interaction strain Â treatment was found for locomotion (F(1, 18) = 5.52, P < 0.05) and motility (F(1, 18) = 4.85, P < 0.05). Analysis of total activity for treatment showed that Nurr1 heterozygous ( þ /À) mice were more active than wild-type in locomotion (137%; P < 0.01, two-tailed Student's t-test) and motility (97%; P < 0.01, two-tailed Student's t-test).
Haloperidol (0.1 mg/kg, i.p.; Figure 3a and b), markedly reduced the elevated locomotor and motility activity of Nurr1 heterozygous ( þ /À) mice.
However, at the dose of haloperidol used (0.1 mg/kg, i.p.) the locomotor activity of wild-type male mice was also suppressed. Thus, the level of locomotor activity in both Nurr1 ( þ /À) and wild-type mice was at about the same magnitude after treatment with haloperidol.
Passive avoidance learning deficit in Nurr1 heterozygous ( þ /À) male mice Nurr1 heterozygous ( þ /À) male or female mice did not differ in their step-through training latency compared with their respective wild-type controls. Training latencies were in the range of approximately 20-30 s in all groups, which indicates that none of the groups had any apparent motor problems, or any bias for the dark vs the light compartment. Memory for the PA task was examined 24 h after training. The stepthrough retention latencies in wild-type male mice were in the range of 150 s, indicating that the animals had acquired the task. However, a decrease in retention latency was observed in Nurr1 heterozygous ( þ /À) male mice, 45% vs wild-type; Figure 4a , indicative of an impairment of PA retention in Nurr1 heterozygous ( þ /À) male mice. Also Nurr1 heterozygous ( þ /À) female mice showed a decrease in retention latency, which was somewhat less than the decrease seen in male mice (35% vs wild-type; Figure 4b ).
A depression-like profile in Nurr1 heterozygous ( þ /À) mice revealed in the forced-swimming test The forced swim test (FST) or Porsolt test is a behavioral test for 'depression-like behavior' in rodents. The test is based on the hypothesis that exposure to a stressful experience, for example water stress, results in a state of learned helplessness or in behavioral despair.
Nurr1 heterozygous ( þ /À) male mice showed a depression-like profile compared to wild-type animals. During the 15 min pretest, wild-type and Nurr1 heterozygous ( þ /À) male mice demonstrated high levels of immobility and low frequencies of the other active behaviors, climbing and swimming. However, these changes did not differ statistically between wild-type and Nurr1 heterozygous ( þ /À) male mice. However, when reexposed to water 24 h later ( Figure  4c ), the Nurr1 heterozygous male mice showed a typical 'depression-like' profile compared to corresponding wild-type mice. Nurr1 heterozygous ( þ /À) male mice were characterized by a much higher immobility time (50%) compared to wild-type male mice (P < 0.001). It is notable that the two groups of mice did not differ at the first exposure to water but only at the second exposure. This indicates that Nurr1 ( þ /À) mice probably are deficient in coping with the stressful experiences.
Brain dopamine and serotonin are changed in Nurr1 heterozygous ( þ /À) mice Since Nurr1 is involved in dopaminergic cell differentiation, it is important to determine whether changes in Nurr1 gene expression in cortical and subcortical areas will affect DA transmission or other monoamines in the adult central nervous system, brain areas implicated in the schizophrenic symptomatology. By using HPLC tissue levels of the main monoamine, transmitters and their metabolites were analyzed including DA, HVA, DOPAC, 5-HT, 5-HIAA and NA. The ratios of DOPAC/DA, HVA/DA and 5-HIAA/5-HT were calculated as a measure of monoamine turnover. This analysis was performed in the pFCx, Hp, St, Mb and Ce of male and female mice and the results are presented in Table 1 and Figure 5 .
Dopamine. There were significant reductions in DA tissue levels in Nurr1 heterozygous ( þ /À) male mice as compared to wild-type control mice (Figure 5a , c and e) in the following region: pFCx (À59%) and Hp (À38%) while DA levels in St and Mb remained unchanged. Also DOPAC levels were reduced in pFCx (À35%) and Hp (À41%). HVA levels in the pFCx tended to be reduced while they were significantly reduced in the St. Based on DOPAC/DA or HVA/DA ratio, DA turnover in St was reduced (HVA/DA ratio; À19%). In contrast, there was a significant increase in the DA turnover in the pFCx (DOPAC/DA ratio; þ 147%).
Unlike male mice, Nurr1 heterozygous ( þ /À) female mice showed elevated DOPAC (39%) and HVA levels in St (12%) (Figure 5b, d and f) . Moreover, an enhancement of DA turnover in St calculated as the DOPAC/DA (52%) and HVA/DA (23%) ratio was observed in Nurr1 ( þ /À) female mice, while DA turnover in the pFCx was unchanged. Notably no gender-specific changes in DA levels were found in the cell body area of the Mb.
Serotonin. Nurr1 heterozygous ( þ /À) male mice showed a significant reduction in 5-HIAA in St (À10%), Hp (À13%) and Mb (À13%); as well as a decrease in 5-HT turnover (5-HIAA/5-HT ratio) in St (À18%), Hp (À19%) and Mb (À18%) (Figure 5c and e). In contrast to male mice, Nurr1 heterozygous ( þ /À) female mice displayed increased concentrations of 5-HT in Mb (7%); 5-HIAA in pFCx (11%), St (13%) and Hp (21%); and increased 5-HT turnover (5-HIAA/ 5-HT ratio) in St (20%), Ce (31%) and Hp (20%). The reduction in 5-HT levels in Ce (À25%) was significant in Nurr1 heterozygous ( þ /À) female mice (Figure 5b, d, f) .
Noradrenaline. Nurr1 heterozygous ( þ /À) male mice showed an increase in NA (28%) in St while Nurr1 heterozygous ( þ /À) female mice displayed increased NA levels in Hp (11%) ( Table 1) .
Discussion
Schizophrenia is a chronic disorder with a complex symptomatology probably related to dysfunctions in cortical and subcortical dopaminergic, serotonergic and glutamatergic transmission. Studies in humans and mouse mutants have identified several genes that increase susceptibility to schizophrenia. Nurr1 gene is of interest since it is a key factor in the neurodevelopmental control of DA neurons in the SNpc and VTA. [16] [17] [18] Moreover, it regulates genes of importance for the maturation and maintenance of a normal DA phenotype. 16, 19, 20 In addition, a Nurr1 mutation has been demonstrated in a few schizophrenic patients. 22 Recently, a reduction of Nurr1 expression in the pFCx was found both in schizophrenia and bipolar disorder. 23 The spontaneous locomotor activity was significantly higher in Nurr1 heterozygous ( þ /À) male and female mice (Figures 1 and 2 ) compared to the control wild-type mice. This indicates that the Nurr1 ( þ /À) mice are hyperactive in a novel environment and it is consistent with rodent animal models of schizophrenia. 30 Spontaneous hyperlocomotion is considered a behavior mediated by increased DAergic tone in the nigrostriatal and mesolimbic DA system. 31 The observation that the classical antipsychotic drug haloperidol 32 fully blocked the hyperactivity in Nurr1 ( þ /À) heterozygous mice supports the notion that the hyperactivity could be mediated via increased DA transmission and stimulation of DA D 2 receptors.
This hypothesis receives further support by the finding that the locomotor response to AMPH administration was enhanced in Nurr1 ( þ /À) mice. The motor stimulatory action of AMPH is thought to be mainly due to enhanced DA release. 31 However, it is not possible to relate the hyperactivity in Nurr1 ( þ /À) mice to a direct increase in striatal DAergic activity. The neurochemical analysis showed a decreased DA turnover in the St in male Nurr1 ( þ /À) mice, while an enhanced DA turnover was found in female mice. On the other hand, DA turnover was increased in the pFCx in male mice but unchanged in female Nurr1 ( þ /À) mice. Gender differences were also seen in 5-HT mechanisms since a decrease in striatal 5-HT turnover was observed in Nurr1 ( þ /À) male mice while the females displayed an increase. It is therefore important to consider the role of 5-HT in a rodent model relevant for schizophrenia since 5-HT is known to modulate both striatal and mesolimbic neurons in a complex manner, dependent on the activation of 5-HT receptor subtypes.
Nurr1 ( þ /À) heterozygous mice also displayed an exaggerated response to the NMDA receptor antagonist PCP. The psychotomimetic drug PCP induces symptoms in humans that closely mimic schizophrenia. 11 It seems conceivable that the spontaneous hyperactivity and the hyperresponse to AMPH/PCP in Nurr1 ( þ /À) mice reflect imbalances in the reciprocal striatal-cortical regulatory mechanisms indicated by an increase in DA turnover in the pFCx heterozygous female adult mice. Data are expressed as nmol/g tissue weight, n = 9-11 animals per group. *Statistically different from wild-type group, P < 0.05, Student's t-test. **Statistically different from wild-type group, P < 0.01, Student's t-test. ***Statistically different from wild-type group, P < 0.001, Student's t-test. Prefrontal cortex, pFCx; wild-type, wt.
Reduced Nurr1 expression as a schizophrenia model P Rojas et al and a decrease in the St. This regulatory adaptation would mean that prefrontal glutamate transmission is deficient, while subcortical DA transmission is overactive. 10 This model provides a possible explanation for our observation that the augmented locomotor response to PCP in Nurr1 heterozygous ( þ /À) mice is mediated by changes in subcortical and cortical DA and NMDA transmission, respectively. Taken together, the Nurr1 ( þ /À) mice display an exaggerated locomotor responses to the psychostimulants/hallucinogens AMPH and PCP, consistent with animal models of schizophrenia. 31 In this respect, Nurr1 ( þ /À) mice differ from mice with reduced NMDA receptor expression because they display a reduced motor stimulation after PCP treatment. 33 Gender-specific differences have been implicated in the etiology of schizophrenia. 34 The clear evidence for gender differences in neurochemical and behavioral effects of the heterozygous Nurr1 mice suggests that the Nurr1 gene's regulation is controlled by gender-specific hormones, such as estrogen or testosterone. This finding is important since sex steroids can affect the development of DA neurons and their function. 35 The analysis of DA levels shows the importance of Nurr1 gene for the maintenance of normal DA neurotransmission in the nigrostriatal, mesolimbic and mesocortical pathways in adult mice. DAergic hyperactivity has been the major hypothesis explaining the pathophysiology of schizophrenia involving disturbed DA transmission in mesolimbic and mesocortical pathways. 10 However, the neurochemical correlates to schizophrenia related to the DA hypothesis have remained elusive. Measurements of DA levels and DA receptor densities in postmortem schizophrenic brains have not provided any clear evidences for increases for DA transmission or DA D 2 receptors in schizophrenia. 10, 36 However, schizophrenic patients appear to have altered DA utilization in cortical-striatal systems indicative of complex changes in DA transmission also in pFCx. 37 Dysregulation of DA transmission of the pFCx has been mainly related to working memory deficits seen in schizophrenic patients. 38 However, cognitive impairments in schizophrenia involve a spectrum of functions including impaired emotional learning. 39 Schizophrenic patients are known to display abnormalities in emotional learning but it is unclear whether deficits in emotional memory are part of a general cognitive impairment. 40 To examine the possible impairments in emotional memory in Nurr1 ( þ /À) mice, we studied their performance in the PA task, a test of emotional memory. 26 The data obtained in the PA task provide direct evidence that Nurr1 heterozygous mice have a reduced ability to form a long-term emotional memory. Several studies indicate that this task is dependent on both hippocampal and amygdala mechanisms. 41, 42 Moreover, hippocampal 5-HT and 5-HT 1A receptors are important for emotional learning in the rat. 42, 44 In this context, the finding of gender differences in 5-HT turnover in the St and Hp intriguing indicates the possibility for sexdependent control of the mood-related behavioral functions. Depression is a frequent comorbidity in schizophrenic patients with appearance to have changes in serotonergic transmission 43 probably related to some of the negative symptomatology seen in schizophrenia.
Schizophrenia patients often display an increased sensitivity to stress indicated by a reduced ability to cope with stressful situations. 45 In the FST Nurr1 heterozygous ( þ /À) male mice (female mice were not tested) showed a depression-like state. This finding indicates problems in coping with stress, evidenced by an increased in immobility-time not on the first but on the second exposure to the inescapable swim stress. This finding is consistent with the observation that the expression of the Nurr1 gene was rapidly and widely upregulated after swim stress in control mice (to be published). The increase in Nurr1 mRNA expression measured by in situ hybridization was not only found throughout the brain including cortical areas, and Hp but also monoamine cell bodies. It seems possible that this transcription factor serves as a modulator of gene expression in wide areas of the brain, probably acting as an important physiological stress regulator. These results are consistent with a regulatory role for this nuclear receptor in response to altered neuronal activity. 46 It is possible that the hypothesized regulatory role of Nurr1 in stress is responsible not only for the behavioral changes observed in Nurr1 ( þ /À) mice in behavioral tests involving exposure to stress but may also be relevant for symptoms of schizophrenia.
